Arrowhead Research reported $-20732000 in Net Income for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agios Pharmaceuticals AGIO:US $ -97.66M 1.32M
Alnylam Pharmaceuticals ALNY:US $ -243.54M 9.75M
Arena Pharmaceuticals ARNA:US $ -122.16M 24.72M
Arrowhead Research ARWR:US $ -20732000 27.7M
Bluebird Bio BLUE:US $ -199.87M 5.13M
Cerulean Pharma CERU:US $ -7.58M 0.46M
Dicerna Pharmaceuticals DRNA:US $ -36.59M 14.74M
Heron Therapeutics HRTX:US $ -62.28M 4.05M
Intercept Pharmaceuticals ICPT:US $ -52.15M 14.32M
Ligand Pharmaceuticals LGND:US $ 5.76M 12.46M
Merk MRK:US $ -2094M 5035M
Mirati Therapeutics MRTX:US $ -101.09M 13.75M
Moderna Inc MRNA:US -272485000 38.85M
Nektar Therapeutics NKTR:US $ -117.2M 8.62M
Novartis NOVN:VX SF 2094M 159M
Opko Health OPK:US $ 32.3M 8.58M
Spectrum Pharmaceuticals SPPI:US $ -48.45M 16.37M
Ultragenyx Pharmaceutical RARE:US $ -24.01M 44.83M
Vertex Pharmaceuticals VRTX:US $ 604.19M 63.24M
Xencor XNCR:US $ -13.69M 1.14M
YTE INCY:US $ 149.85M 165.05M